CompaniesNephrogen

Nephrogen

active

New York, NY, United States

Founded 2015

About

Gene Therapy for Kidney Disease

Areas of Focus

Categories

Gene Therapy, RNA & Peptide TherapyNJ, NY, PA

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

350

By Status

NOT_YET_RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2024

2025

2026

2027

2028

2029

Today

Hover over trial bars to see details

Recent Trials

NCT06792448Collaborator

Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics Study

N/ANot yet recruiting

350 participants

Started: Feb 15, 2025 · Completed: Jun 1, 2028

Funding History (20)

8-K

May 24, 2017

8-K

May 19, 2017

8-K

May 11, 2017

8-K

Apr 21, 2017

8-K

Apr 20, 2017

8-K

Mar 24, 2017

8-K

Mar 15, 2017

8-K

Mar 1, 2017

8-K

Feb 17, 2017

8-K

Feb 16, 2017

Locations (1)

Headquarters

New York, NY, United States

Map

Loading map...